Investing Profile

Aaron Royston

InvestorVC
Managing Partner at venBio Partners
venbio.com/aaron.htmlSan Francisco Bay Area
Photo of Aaron Royston, Managing Partner at venBio

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
venBio Managing Partner
$20.0M - $30.0M
$25.0M
17
CompanyStageDateRound SizeTotal Raised
Marea Therapeutics
Series BJun 2024$190M
$260M
Co-investors: Jeffrey Tong (Third Rock Ventures), Maha Katabi (Sofinnova Investments), Charles Homcy (Third Rock Ventures), Chris Garabedian (Perceptive Advisors)
Attovia Therapeutics
Series BMay 2024$110M
Series AJun 2023$60M
$170M
Co-investors: James N. Topper (Frazier Healthcare Partners)
Ceptur Therapeutics
Series AJan 2022$75M
$75M
Ablaze Pharmaceuticals
Series ANov 2021$75M
$75M
Co-investors: Hongbo Lu (Vivo Capital)
HistoWiz
Series AOct 2021$32M
$32M
Co-investors: Nathan Dau (Vivo Capital), Evan Cheng
INBRACE
Series DSep 2021$100M
Series COct 2019$45M
$150M
Co-investors: Peter Moldt (Novo Ventures), Joseph Siletto (Vivo Capital)
Neurogastrx
Series BAug 2021$60M
Series AJan 2018$45M
$110M
Co-investors: Klaus Veitinger (OrbiMed), David Allison (Westlake Village BioPartners)
RayzeBio
Series CJun 2021$110M
Series BDec 2020$110M
Series AOct 2020$45M
$420M
Co-investors: Jerel Davis (Versant Ventures), Bong Koh (Venrock), bong koh (KohFounders), Maha Katabi (Sofinnova Investments)